Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Amgen Inc (AMGN.O)

AMGN.O on Nasdaq

154.28USD
1 Jul 2016
Change (% chg)

$2.13 (+1.40%)
Prev Close
$152.15
Open
$152.43
Day's High
$154.95
Day's Low
$152.25
Volume
2,758,071
Avg. Vol
3,138,400
52-wk High
$181.81
52-wk Low
$130.09

Harper, Sean 

Dr. Sean E. Harper is the Executive Vice President - Research and Development of Amgen Inc. Dr. Harper joined the Company in 2002, and has held leadership roles in early development, medical sciences and global regulatory and safety. Dr. Harper served as Senior Vice President, Global Development and Corporate Chief Medical Officer from March 2007 to February 2012. Prior to joining the Company, Dr. Harper worked for five years at Merck Research Laboratories.

Basic Compensation

Total Annual Compensation, USD 899,948
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 4,707,880
Fiscal Year Total, USD 5,607,820

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 8,000 447,070.00
Name Fiscal Year Total

Robert Bradway

16,097,700

David Meline

6,592,620

Madhavan Balachandran

4,986,140

Sean Harper

5,607,820

Anthony Hooper

6,414,730

Brian McNamee

--
As Of  30 Dec 2015